FDA advisers back tamper-proof version of OxyContin

09/24/2009 | Bloomberg

An FDA panel recommended approval of Purdue Pharma's tamper-proof version of pain drug OxyContin. The formulation has a chemical additive that minimizes the release of oxycodone when the pill is chewed or crushed.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC